The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...
PD Dr Yuri Tolkach Institute of Pathology at University Hospital Cologne +49 221 478 6365 iurii.tolkach@uk-koeln.de ...
Hosted on MSN
AI pathology system SPARK offers new cancer insights
Researchers at University Hospital Cologne have developed SPARK, an AI-based pathology framework that autonomously generates and refines biological hypotheses from tissue images. Tested on over 5,400 ...
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine pathology samples.
Roche (RHHBY) stock rises 1.55% following announcement of PathAI acquisition for $750M, enhancing AI-powered cancer ...
Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...
Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified ...
For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an "identity crisis." Normally, a B cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results